Norinchukin Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.77M Buy
21,936
+1,859
+9% +$828K 0.15% 103
2025
Q1
$9.73M Buy
20,077
+6,120
+44% +$2.97M 0.18% 90
2024
Q4
$5.62M Buy
13,957
+1,106
+9% +$445K 0.12% 109
2024
Q3
$5.98M Buy
12,851
+1,716
+15% +$798K 0.14% 96
2024
Q2
$5.22M Buy
11,135
+5
+0% +$2.34K 0.15% 89
2024
Q1
$4.65M Sell
11,130
-237
-2% -$99.1K 0.14% 95
2023
Q4
$4.63M Sell
11,367
-1,659
-13% -$675K 0.11% 93
2023
Q3
$4.53M Sell
13,026
-13,803
-51% -$4.8M 0.11% 104
2023
Q2
$9.44M Buy
26,829
+6,622
+33% +$2.33M 0.16% 103
2023
Q1
$6.37M Buy
20,207
+522
+3% +$164K 0.13% 110
2022
Q4
$5.68M Sell
19,685
-4,391
-18% -$1.27M 0.12% 117
2022
Q3
$6.97M Buy
24,076
+2,438
+11% +$706K 0.14% 105
2022
Q2
$6.1M Sell
21,638
-4,719
-18% -$1.33M 0.12% 113
2022
Q1
$6.88M Buy
26,357
+2,482
+10% +$648K 0.09% 131
2021
Q4
$5.24M Sell
23,875
-1,919
-7% -$421K 0.07% 154
2021
Q3
$4.68M Buy
25,794
+1,399
+6% +$254K 0.07% 160
2021
Q2
$4.92M Buy
24,395
+217
+0.9% +$43.8K 0.07% 143
2021
Q1
$5.2M Buy
24,178
+1,135
+5% +$244K 0.07% 133
2020
Q4
$5.45M Sell
23,043
-132
-0.6% -$31.2K 0.08% 123
2020
Q3
$6.31M Buy
23,175
+778
+3% +$212K 0.1% 102
2020
Q2
$6.5M Buy
22,397
+9
+0% +$2.61K 0.11% 97
2020
Q1
$5.33M Sell
22,388
-12,421
-36% -$2.96M 0.1% 100
2019
Q4
$7.62M Sell
34,809
-3,008
-8% -$659K 0.1% 126
2019
Q3
$6.41M Buy
37,817
+1,004
+3% +$170K 0.09% 146
2019
Q2
$6.75M Sell
36,813
-12,442
-25% -$2.28M 0.1% 128
2019
Q1
$9.06M Buy
49,255
+1,726
+4% +$317K 0.12% 129
2018
Q4
$7.88M Buy
47,529
+14,658
+45% +$2.43M 0.11% 130
2018
Q3
$6.34M Buy
32,871
+3,998
+14% +$771K 0.09% 136
2018
Q2
$4.91M Buy
28,873
+5,608
+24% +$953K 0.07% 142
2018
Q1
$3.79M Buy
23,265
+3,046
+15% +$496K 0.06% 148
2017
Q4
$3.03M Buy
20,219
+1,454
+8% +$218K 0.05% 169
2017
Q3
$2.85M Buy
18,765
+1,481
+9% +$225K 0.06% 186
2017
Q2
$2.23M Buy
17,284
+1,140
+7% +$147K 0.05% 228
2017
Q1
$1.77M Buy
16,144
+1,097
+7% +$120K 0.04% 254
2016
Q4
$1.11M Buy
15,047
+1,781
+13% +$131K 0.03% 308
2016
Q3
$1.16M Buy
13,266
+292
+2% +$25.5K 0.03% 293
2016
Q2
$1.12M Buy
12,974
+329
+3% +$28.3K 0.03% 281
2016
Q1
$1.01M Buy
12,645
+1,166
+10% +$92.7K 0.02% 299
2015
Q4
$1.44M Sell
11,479
-2,516
-18% -$317K 0.04% 246
2015
Q3
$1.46M Buy
13,995
+195
+1% +$20.3K 0.04% 252
2015
Q2
$1.7M Sell
13,800
-553
-4% -$68.3K 0.04% 248
2015
Q1
$1.69M Buy
14,353
+180
+1% +$21.2K 0.04% 246
2014
Q4
$1.68M Buy
14,173
+4,614
+48% +$548K 0.04% 232
2014
Q3
$1.07M Buy
9,559
+746
+8% +$83.8K 0.03% 205
2014
Q2
$834K Sell
8,813
-943
-10% -$89.2K 0.02% 220
2014
Q1
$690K Buy
9,756
+1,024
+12% +$72.4K 0.02% 256
2013
Q4
$649K Sell
8,732
-12
-0.1% -$892 0.02% 245
2013
Q3
$663K Buy
+8,744
New +$663K 0.02% 231